manufacturing update, page-18

Hi Livas1,

I can't imagine Therapex would have entered into a contract with EMS for MFG rights in the first instance if there were any outstanding unresolved issues with BP. Maybe a conditional agreement pending relolution?

But to have "progressed the manufacturing process substantially over the past four months...to be on track to produce registration batches in December...with scale-up testing now complete...analytical and technical development programs well advanced....with the capital improvement programs on the ArtiMist filling equipment and filling room modifications underway to allow for the manufacture of ArtiMist," that's a significant investment in financial and human resources on the "hope" that everything is okay.

I'd hazard a guess that companies like Therapex don't operate on a wing and a prayer when signing off on, and implementing, capital investment programs.

It's inconvenient for investors to not have closure on BP, but all the signs suggest both companies are proceeding on the basis that all issues have been, or soon will be, resolved.